article thumbnail

Insulin prices demonstrate pharma’s greed

World of DTC Marketing

According to the Mayo Clinic “The 3 main reasons cited by pharmaceutical companies for the high cost of new prescription drugs do not apply to insulin. In the five-yearperiodfrom2016to2020, pharmaceutical companies raised the prices of branded prescription drugs by 36%—almost four times the rate of inflation during that period.

article thumbnail

Opioid Prescriptions for US Patients With Cancer, Non-Cancer Pain Falls, Study Results Show

Pharmacy Times

Analysis looks at those with arthritis, chronic pain, headaches, lower back pain, and neuropathic pain between 2012 and 2019.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Owlet Announces FDA-Clearance of the First Prescription Pulse Oximetry Sock for Infants

Legacy MEDSearch

Available through prescription, BabySat uses pulse oximetry technology to provide a real-time display of their baby’s heart rate and oxygen saturation level (SpO2) and alerts parents when these readings fall outside of prescribed ranges. Owlet was founded by a team of parents in 2012. To learn more, visit www.owletcare.com.

article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

1 For use as prescription drugs, a botanical product must be approved by the FDA: to date, only two have gained this approval. 2 It was first approved as Fulyzaq in December 2012 and in October 2016, Napo Pharmaceuticals launched the new brand, Mytesi. 2012/1916). 2012/1916). 3 Is two too few?

Marketing 103
article thumbnail

Improving Patient Portal Engagement with Pharma Content

PM360

Typically, results or new treatment prescriptions are simply uploaded to the portal with the doctors expected to give explanations during the appointment—even though the ability to provide additional information within the portal is readily available.

Pharma 105
article thumbnail

Innovating allergy drug delivery with a needle-free alternative

European Pharmaceutical Review

However, reports and surveys say that only half of people with an epinephrine needle-injector prescription consistently carry their device, 4 and for patients and caregivers who do carry a needle-injector, more than half either delay or do not administer it in an emergency. Hand (N Y). 2007; 2(1):5-11. Derived from IQVIA Claims Data, 2023.

article thumbnail

Planning for 2023: 10 Advanced Strategies for Marketing & Advertising 

Healthcare Success

According to Axios, traditional pay-TV providers like Comcast, Verizon, and Dish Network have lost a staggering 25 million subscribers since 2012 and are expected to lose another 25 million by 2025. For example, pharma marketers can track and attribute increased prescriptions to specific ad campaigns. Your ads should be streaming, too.